The Clinical Features of Combined Central and Peripheral Demyelination
NCT04664647 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2020-12-16
Summary
The investigators conduct this study to clarify the clinical features and to evaluate the prevalence of anti-nodal/paranodal antibodies of patients with combined central and peripheral demyelination (CCPD) .
Conditions
- Combined Central and Peripheral Demyelination Disease
Sponsors & Collaborators
-
Xuanwu Hospital, Beijing
lead OTHER
Principal Investigators
-
Junwei Hao · Xuanwu Hospital, Beijing
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-12-31
- Primary Completion
- 2020-12-31
- Completion
- 2021-01-31
More Related Trials
-
Central and Peripheral Nervous System Changes as Markers of Disease Progression in Multiple Sclerosis
NCT03401307 ·Status: COMPLETED
-
Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy
NCT05849467 ·Status: RECRUITING ·Phase: PHASE1
-
CHRONIC OPTIC NEUROPATHY IN MULTIPLE SCLEROSIS
NCT02543788 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Impact of Lesions of the Motor and Proprioceptive Brain and Pan-medullary Pathways on Their Clinically and Electrophysiologically Assessed Function in Multiple Sclerosis
NCT04220814 ·Status: COMPLETED ·Phase: NA
-
Phase Ib Study to Evaluate MOR103 in Multiple Sclerosis
NCT01517282 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Cohort Study of Clinically Isolated Syndrome and Early Multiple Sclerosis
NCT01371071 ·Status: UNKNOWN
-
Baseline Cortical Haemodynamics in MS
NCT02481882 ·Status: UNKNOWN ·Phase: NA
-
Quantitation of McArdle's Sign and Evaluation of Specificity for Multiple Sclerosis
NCT03122873 ·Status: COMPLETED
-
Rehabilitative Protocols in Progressive Multiple Sclerosis Treated with Anti CD20 Monoclonal Antibodies
NCT06894940 ·Status: COMPLETED ·Phase: PHASE2
-
Role of Neuromuscular Junction Function in Motor Fatigue in Multiple Sclerosis
NCT02418897 ·Status: COMPLETED
-
Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Progressive Multiple Sclerosis and Neuromyelitis Optica
NCT01364246 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study of Empathy in MS
NCT05332951 ·Status: COMPLETED
-
Visual (Path)Ways in Multiple Sclerosis - Part II
NCT06776224 ·Status: COMPLETED ·Phase: NA
-
Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis
NCT05177523 ·Status: RECRUITING
-
Spinal Cord Analysis in Multiple Sclerosis
NCT03841903 ·Status: COMPLETED
-
Neuropsychiatric Scleroderma Study: Systematic Evaluation of Neuropsychiatric Involvement in Systemic Sclerosis
NCT01488214 ·Status: COMPLETED ·Phase: NA
-
Assessment of Patients With Multiple Sclerosis (MS)
NCT00001156 ·Status: COMPLETED
-
MRI Biomarkers Predictive of Disability Progression in Patients With Multiple Sclerosis
NCT05491031 ·Status: RECRUITING ·Phase: NA
-
Fatigue in Multiple Sclerosis: Evaluated With 3 MRI and Transcranial Magnetic Stimulation
NCT00342381 ·Status: COMPLETED ·Phase: PHASE2
-
Regulation of Lipid Metabolism in Autoimmune Disease: Multiple Sclerosis
NCT04053374 ·Status: UNKNOWN
-
Pathological Basis of MRI Signal Changes in Multiple Sclerosis
NCT02659956 ·Status: RECRUITING
-
Predictive Value of the Optic Nerve Involvement in Clinically Isolated Syndrome
NCT06455332 ·Status: RECRUITING ·Phase: NA
-
Treatment Response Among Chinese Neuromyelitis Optica Spectrum Disorders
NCT04101058 ·Status: UNKNOWN
-
Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
NCT00794352 ·Status: RECRUITING
-
Copaxone Subcutaneous Injection Syringe Special Drug Use-Result Investigation (All-Case Investigation) "Prevention of Relapse of Multiple Sclerosis"
NCT03209479 ·Status: COMPLETED